George Eric Davis
EVP, Chief Legal Officer at Biomarin Pharmaceutical · 5 reported transactions in 1 company · latest trade Sep 2, 2026
Their trades
Sold | Sep 2, 2026 | Sep 2, 2026 close $66.97 → Oct 23, 2026 close $55.95. S&P 500 −0.7% over the same days. | ||
Sold | Feb 26, 2026 | Feb 26, 2026 close $61.11 → Oct 23, 2026 close $55.95. S&P 500 +10.3% over the same days. |
$1.16M
Sep 2, 2026 close $66.97 → Oct 23, 2026 close $55.95. S&P 500 −0.7% over the same days.
$1.6M
Feb 26, 2026 close $61.11 → Oct 23, 2026 close $55.95. S&P 500 +10.3% over the same days.